InvivoGen
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables them to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
More information at https://www.invivogen.com.
InvivoGen
Dual IRF and IFN-β reporter 293 cells expressing A162 isoform of human STING (S162A)
InvivoGen
Dual IRF and IFN-β reporter 293 cells expressing H232 isoform of human STING (R232H)
InvivoGen
Dual IRF and IFN-β reporter 293 cells expressing R232 isoform of human STING
